PPARA and metabolic dysfunction-associated steatotic liver disease: Although PPARA mRNA levels remained unchanged in the conditions tested in the present work, human liver chimeric mice recapitulated the increase in SREBP1c gene expression, further supporting the involvement of this transcription factor in early stages of human NAFLD.